scispace - formally typeset
M

Mikkel Porsborg Andersen

Researcher at Aalborg University

Publications -  46
Citations -  756

Mikkel Porsborg Andersen is an academic researcher from Aalborg University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 27 publications receiving 337 citations.

Papers
More filters
Journal ArticleDOI

Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.

TL;DR: The results showing only modest effects of CVDs on increased risks of poor COVID-19 outcomes are important in allowing public health authorities and clinicians to provide more tailored guidance to cardiovascular patients, who have heretofore been grouped together as high risk due to their disease status.
Journal ArticleDOI

All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study.

TL;DR: In this paper, the authors investigated mortality rates, overall and according to location, in patients with established cardiovascular disease before, during, and after lockdown measures in Denmark and found that the overall, in-hospital, and out-of-hospital mortality rate in 2020 before lockdown was significantly lower compared with the same period in 2019 [adjusted incidence rate ratio (IRR) 0.87, 95% CI 0.83-0.93, respectively].
Journal ArticleDOI

Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.

TL;DR: To compare the hazard of all‐cause, chronic obstructive pulmonary disease (COPD) and heart failure (HF) hospitalization in carvedilol vs. metoprolol/bisoproll/nebivolol users with COPD and concurrent HF from 2009 to 2012, and to evaluate the use and persistence in treatment of these β‐blockers, their impact on the risk of COPD‐related hospitalization, and the factors important for their selection.